- Organizations: EssilorLuxottica
Business
EssilorLuxottica purchases RetinAI
Ikarian subsidiary is the developer of the FDA-cleared Discovery platform, an AI-based imaging data management system for diagnosing and monitoring ophthalmic disease progression.Products
FDA authorizes marketing of Essilor Stellest eyeglass lenses for myopia
The first eyeglass lenses authorized for marketing to slow the progression of pediatric myopia will be available in the U.S. in the coming weeks.Products
Essilor introduces Cellview Retinal Camera with widefield fundus imaging
Easy-to-use retinal imager makes its Essilor debut at Vision Expo West over 6 months after its acquisition.Business
Meta reportedly buys minority stake in EssilorLuxottica
The estimated $3.51 billion investment follows companies’ recent plans to launch AI-powered smart glasses for the Oakley sports performance frames this summer.Products
FDA clears EssilorLuxottica's NuanceAudio for US market
Stylized eyeglass frames feature advanced hearing technology and Transitions lenses; expected to launch in Q1 2025.Events
Eyecare companies offering support to LA wildfire victims
Industry leaders such as CooperVision, Alcon, Bausch + Lomb, and EssilorLuxottica are providing supplies and services to optometrists and residents in need.Products
EssilorLuxottica's Nuance Audio pairs sight and sound
Nuance Audio combines proprietary software with fashion-forward glasses for a new consumer demographic.Products
EssilorLuxottica debuts Transitions-powered Ray-Ban frames
Latest addition to iconic brand features original Wayfarer designs and light-responsive, color-changing frames.Business
EssilorLuxottica is purchasing a majority stake in Heidelberg Engineering
Multinational eyewear corporation will acquire an 80% stake in the high-tech solutions company.Products
EssilorLuxottica demos advanced eyewear with hearing technology
Nuance Audio combines proprietary software with fashion-forward glasses for a new demographic of consumers.Research
New data supports HAL spectacle lenses for myopia
Four-year data builds on 3-year findings in pediatric myopia control.Products